Epcoritamab for treating relapsed or refractory follicular lymphoma after 2 or more systemic treatments [ID6338]

  • In development
  • GID-TA11385
  • Expected publication date: TBC

Documents

Documents created during the development process.

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6338